(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

REGENXBIO

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

REGENXBIO

ST13

US500000086397653

Classe

42

Pedido

86397653

Registro

5018428

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

78

Atualização mais recente

28/07/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

42

Data de depósito

17/09/2014

Data de registro

09/08/2016

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

09/07/2026

Última transação

28/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

01/09/2014

Primeiro uso no comércio

01/09/2014

Código do desenho

4

Tipo de titular

03

Localização do titular

Rockville, MD, US

Examinador

THOMAS, AMY E

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

REGENXBIO Inc.

Representantes

William R. Samuels COLE-FRIEMAN & MALLON LLP

Classificação técnica

Classes Nice

Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Custom development of biochemical reagentssynthesis for others of clinical medical reagents for use in gene therapydevelopment of pharmaceutical preparations for use in gene therapytherapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapyRNA interference (RNAi); Scientific and medical research and development; genetic engineering servicesbiotechnology research servicesresearch and development of new products in the field of gene therapeutics and research toolsincluding those based on recombinant adeno-associated viral vectors

Publicações

Histórico de despachos e eventos da marca no USPTO.

78 publicações encontradas

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/07/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/07/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/07/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/07/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

07/05/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/08/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/12/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/12/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/12/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/12/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/12/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

17/06/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

17/06/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

17/06/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

19/02/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

18/02/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

18/02/2023

E815

TEAS SECTION 8 & 15 RECEIVED

03/08/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/08/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

21/06/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

21/06/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

21/06/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

21/06/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

21/06/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/08/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/08/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/08/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/08/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/08/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

21/06/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

21/06/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

21/06/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

21/06/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

21/06/2020

CCON

COUNTERCLAIM OPP. NO. 999999

07/12/2018

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

25/01/2018

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

25/01/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

26/10/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

26/10/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

09/08/2016

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/07/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/07/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

28/06/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

28/06/2016

IUAF

USE AMENDMENT FILED

08/06/2016

EISU

TEAS STATEMENT OF USE RECEIVED

08/06/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/05/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/03/2016

PUBO

PUBLISHED FOR OPPOSITION

15/03/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

24/02/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/02/2016

EXPT

EXPARTE APPEAL TERMINATED

01/02/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/02/2016

ACEC

AMENDMENT FROM APPLICANT ENTERED

29/01/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

29/01/2016

MAIL

PAPER RECEIVED

28/01/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/01/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/01/2016

ALIE

ASSIGNED TO LIE

22/01/2016

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

11/01/2016

EXPI

EX PARTE APPEAL-INSTITUTED

11/01/2016

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

11/01/2016

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

11/01/2016

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/07/2015

GNFR

FINAL REFUSAL E-MAILED

10/07/2015

CNFR

FINAL REFUSAL WRITTEN

10/07/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/06/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/06/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

25/06/2015

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

23/04/2015

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

23/04/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/01/2015

GNRT

NON-FINAL ACTION E-MAILED

06/01/2015

CNRT

NON-FINAL ACTION WRITTEN

06/01/2015

DOCK

ASSIGNED TO EXAMINER

30/12/2014

MPMK

NOTICE OF PSEUDO MARK E-MAILED

25/09/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/09/2014

NWAP

NEW APPLICATION ENTERED

20/09/2014

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace REGENXBIO ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.